These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 7510073

  • 21. [Summary of our clinical experience with the determination of serum prostate-specific antigen level in the first five years].
    Bánfi G, Kiss F, Kádár A, Romics I.
    Magy Onkol; 2003; 47(2):165-8. PubMed ID: 12975664
    [Abstract] [Full Text] [Related]

  • 22. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E, Stoma F, Michalak A, Latalski M, Goniewicz M.
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia.
    Dehghani M, Mostafavi-Pour Z, Lotfi M, Shakeri S.
    Iran J Immunol; 2009 Jun; 6(2):92-8. PubMed ID: 19561378
    [Abstract] [Full Text] [Related]

  • 24. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 25. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 26. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
    Kuriyama M, Wang MC, Lee CL, Killian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishiura T, Slack NH, Murphy GP, Chu TM.
    J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628
    [Abstract] [Full Text] [Related]

  • 27. Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer.
    Bostwick DG.
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S31-7. PubMed ID: 7524305
    [Abstract] [Full Text] [Related]

  • 28. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH, Hong SJ, Cho JS, Seong DH.
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [Abstract] [Full Text] [Related]

  • 29. [Diagnostic value of complexed prostate-specific antigen for prostate cancer].
    Su HW, Li Y, Xu P.
    Zhonghua Nan Ke Xue; 2003 Sep; 9(6):431-3. PubMed ID: 14574807
    [Abstract] [Full Text] [Related]

  • 30. [Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml].
    Irani J, Millet C, Levillain P, Doré B, Bégon F, Aubert J.
    Chirurgie; 1997 Sep; 122(8-9):478-82. PubMed ID: 9616891
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Significance of prostate fluid carcinoembryonic antigen in the diagnosis of prostate cancer].
    Hayashi T, Yamauchi A, Hosoda K.
    Hinyokika Kiyo; 1995 Jul; 41(7):525-8. PubMed ID: 7545350
    [Abstract] [Full Text] [Related]

  • 33. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA, Kamalov AA, Karpov VK, Riaboĭ AV, Prokhorov AV.
    Urologiia; 2001 Jul; (2):37-40. PubMed ID: 11490716
    [Abstract] [Full Text] [Related]

  • 34. [Prostate-specific antigen in the diagnosis of organ-confined treatable prostate carcinoma].
    Recker F.
    Schweiz Med Wochenschr; 1996 Nov 02; 126(44):1881-90. PubMed ID: 8984601
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Purification of a human prostate specific antigen.
    Wang MC, Valenzuela LA, Murphy GP, Chu TM.
    Invest Urol; 1979 Sep 02; 17(2):159-63. PubMed ID: 89106
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Successful separation between benign prostatic hyperplasia and prostate cancer by measurement of free and complexed PSA.
    Lilja H, Stenman UH.
    Cancer Treat Res; 1996 Sep 02; 88():93-101. PubMed ID: 9239474
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.